Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding

Sponsor
Spital STS AG (Industry)
Overall Status
Completed
CT.gov ID
NCT01234428
Collaborator
Department of Medicine, Spital STS AG Thun (Other)
167
1
1
141
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether esophageal dysmotility and dilatation is an important complication in the long term follow-up following laparoscopic gastric banding for morbid obesity.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic surgery
  • Procedure: gastric banding
N/A

Detailed Description

Using a yearly barium swallow the diameter of the esophagus will be monitored over the period.

Study Design

Study Type:
Interventional
Actual Enrollment :
167 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Esophageal Dysmotility Disorders Following Laparoscopic Gastric Banding - An Underestimated Complication.
Study Start Date :
Jun 1, 1998
Actual Primary Completion Date :
Jun 1, 2009
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Other: surgery

Procedure: Laparoscopic surgery
Gastric banding

Procedure: gastric banding
laparoscopic gastric banding
Other Names:
  • morbid obesity
  • Outcome Measures

    Primary Outcome Measures

    1. esophageal dilatation [yearly follow-up over 12 year period]

      esophageal dilatation or dysfunction

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • BMI more than 40
    Exclusion Criteria:
    • BMI below 40

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Surgery, Spital STS AG Thun Thun Switzerland 3600

    Sponsors and Collaborators

    • Spital STS AG
    • Department of Medicine, Spital STS AG Thun

    Investigators

    • Principal Investigator: Markus Naef, MD, MBA, Spital STS AG Thun, Switzerland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01234428
    Other Study ID Numbers:
    • MOB-12-STS-AG
    First Posted:
    Nov 4, 2010
    Last Update Posted:
    Nov 4, 2010
    Last Verified:
    Nov 1, 2010

    Study Results

    No Results Posted as of Nov 4, 2010